MMedication Read More LLY’s Oral GLP-1 Pill Foundayo Shows Heart Benefits in Diabetes StudyApril 19, 2026 Eli Lilly and Company LLY announced that a phase III study, ACHIEVE-4, evaluating its newly approved oral GLP-1…
MMedication Read More Weight Loss Drugs May Be Making Patients Lose More Than Just FatApril 19, 2026 Researchers at the University of North Carolina (UNC) School of Medicine have found that popular weight loss and…
MMedication Read More The ripple effects of GLP-1sApril 16, 2026 SIOUX FALLS, S.D. (Dakota News Now) – Weight-loss medications are making headlines nationwide, but their impact may be…
HHealth Read More Study links ultra-processed food intake to poorer thigh muscle qualityApril 16, 2026 A new MRI study suggests that diets high in ultra-processed foods may be linked to fattier, poorer-quality thigh…
HHealth Read More Fatty liver cases surge in India, driven by diabetes and obesity: studyApril 14, 2026 Cases of Metabolic dysfunction-associated steatotic liver disease have risen sharply in India since 1990, driven largely by increasing…
MMedication Read More Wegovy HD 7.2mg Now Available for Chronic Weight ManagementApril 11, 2026 Wegovy® HD (semaglutide) injection 7.2mg is now available for adult patients for whom additional weight reduction is clinically…
MMedication Read More Ozempic Shreds Bones? How a Small Study Turned Into a Big Health MythApril 10, 2026 Every drug comes with its trade-offs, including blockbuster weight loss medications like semaglutide (the active ingredient in Ozempic)…
MMedication Read More Surge of generic weight-loss drugs triggers price war in IndiaApril 4, 2026 Open this photo in gallery: Obesity doctor and consultant Swati Pradhan explains the Mounjaro GLP-1 self-injectable device at…
MMedication Read More Emcure reduces price of weight management drug Poviztra by 55%April 3, 2026 Emcure reduces price of weight management drug Poviztra by 55% April 02, 2026 | Thursday | News Price…
MMedication Read More All about new ‘triple-G’ drug that’s helped patients lose a quarter of their body weightApril 2, 2026 G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight…
HHealth Read More Hormonal contraception not associated with prevalence of idiopathic intracranial hypertensionMarch 26, 2026 Hormonal contraception, including birth control pills and intrauterine devices (IUDs), is not associated with an increased prevalence of…
HHealth Read More Wholegrain rye changes gut bacteria and lowers inflammation in obesity trialMarch 25, 2026 A 12-week randomized trial found that wholegrain rye did not beat refined wheat for weight loss, but it…